✦ LIBER ✦

The Efficacy and Tolerability of a Monthly Dosing Regimen of 75mg Risedronate Dosed on 2 Consecutive Days a Month for the Treatment of Postmenopausal Women with Osteoporosis – 2 Year Study Results

✍ Scribed by McClung, Michael; Benhamou, Claude; Man, Zulema; Tlustochowicz, Witold; Zanchetta, Jose; Eusobio, Rachelle; Balske, Ana; Matzkin, Ellen; Recker, Robert

Book ID: 123102294
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 64 KB
Volume: 12
Category: Article
ISSN: 1094-6950
DOI: 10.1016/j.jocd.2009.03.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Novel Monthly Dosing Regimen of Risedr

A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data

✍ Michael R. McClung, Claude-Laurent Benhamou, Zulema Man… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 279 KB

Evidence for safety and efficacy of rise

Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study

✍ Steven Boonen; Roman S. Lorenc; Dietrich Wenderoth; Karen J. Stoner; Rachelle Eu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Multicenter, open-label, dose-area escal

Multicenter, open-label, dose-area escalation, cohort study to evaluate the safety and tolerability of PEP005 (ingenol mebutate) gel 0.05% applied for two consecutive days to treatment area(s) of up to a total of 100cm2 in patients with actinic keratoses

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB